• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

铁调素融合蛋白实现了一种新的Y/Y诊疗方法。

Siderocalin fusion proteins enable a new Y/Y theranostic approach.

作者信息

Cosby Alexia G, Arino Trevor, Bailey Tyler A, Buerger Matthew, Woods Joshua J, Aguirre Quintana Luis M, Alvarenga Vasquez Jennifer V, Wacker Jennifer N, Gaiser Alyssa N, Strong Roland K, Abergel Rebecca J

机构信息

Chemical Sciences Division, Lawrence Berkeley National Laboratory Berkeley CA 94720 USA

Department of Nuclear Engineering, University of California Berkeley CA 94720 USA.

出版信息

RSC Chem Biol. 2023 Jun 15;4(8):587-591. doi: 10.1039/d3cb00050h. eCollection 2023 Aug 3.

DOI:10.1039/d3cb00050h
PMID:37547455
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10398355/
Abstract

The mammalian protein siderocalin binds bacterial siderophores and their iron complexes through cation-π and electrostatic interactions, but also displays high affinity for hydroxypyridinone complexes of trivalent lanthanides and actinides. In order to circumvent synthetic challenges, the use of siderocalin-antibody fusion proteins is explored herein as an alternative targeting approach for precision delivery of trivalent radiometals. We demonstrate the viability of this approach , using the theranostic pair Y (β, = 64 h)/Y (β, = 14.7 h) in a SKOV-3 xenograft mouse model. Ligand radiolabeling with octadentate hydroxypyridinonate 3,4,3-LI(1,2-HOPO) and subsequent protein binding were achieved at room temperature. The results reported here suggest that the rapid non-covalent binding interaction between siderocalin fusion proteins and the negatively charged Y(iii)-3,4,3-LI(1,2-HOPO) complexes could enable purification-free, cold-kit labeling strategies for the application of therapeutically relevant radiometals in the clinic.

摘要

哺乳动物蛋白质铁调素通过阳离子-π和静电相互作用结合细菌铁载体及其铁络合物,但对三价镧系元素和锕系元素的羟基吡啶酮络合物也表现出高亲和力。为了规避合成挑战,本文探索使用铁调素-抗体融合蛋白作为一种替代靶向方法,用于三价放射性金属的精准递送。我们在SKOV-3异种移植小鼠模型中,使用治疗诊断用核素对Y(β,半衰期 = 64小时)/Y(β,半衰期 = 14.7小时)证明了该方法的可行性。在室温下用八齿羟基吡啶酮3,4,3-LI(1,2-HOPO)进行配体放射性标记并随后与蛋白质结合。本文报道的结果表明,铁调素融合蛋白与带负电荷的Y(iii)-3,4,3-LI(1,2-HOPO)络合物之间快速的非共价结合相互作用,可为临床上治疗相关放射性金属的应用实现免纯化、冷试剂盒标记策略。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/51a2/10398355/b16e4662b8d2/d3cb00050h-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/51a2/10398355/f699d77723d6/d3cb00050h-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/51a2/10398355/b16e4662b8d2/d3cb00050h-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/51a2/10398355/f699d77723d6/d3cb00050h-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/51a2/10398355/b16e4662b8d2/d3cb00050h-f2.jpg

相似文献

1
Siderocalin fusion proteins enable a new Y/Y theranostic approach.铁调素融合蛋白实现了一种新的Y/Y诊疗方法。
RSC Chem Biol. 2023 Jun 15;4(8):587-591. doi: 10.1039/d3cb00050h. eCollection 2023 Aug 3.
2
The role of electrostatics in siderophore recognition by the immunoprotein Siderocalin.静电作用在免疫蛋白铁调素识别铁载体中的作用。
J Am Chem Soc. 2008 Dec 24;130(51):17584-92. doi: 10.1021/ja8074665.
3
Developing scandium and yttrium coordination chemistry to advance theranostic radiopharmaceuticals.发展钪和钇配位化学以推进诊疗用放射性药物。
Commun Chem. 2020 May 15;3(1):61. doi: 10.1038/s42004-020-0307-0.
4
Parsing the functional specificity of Siderocalin/Lipocalin 2/NGAL for siderophores and related small-molecule ligands.解析铁调素/脂质运载蛋白2/中性粒细胞明胶酶相关脂质运载蛋白对铁载体及相关小分子配体的功能特异性。
J Struct Biol X. 2019 May 30;2:100008. doi: 10.1016/j.yjsbx.2019.100008. eCollection 2019 Apr-Jun.
5
Specific sequestering agents for the actinides. 21. Synthesis and initial biological testing of octadentate mixed catecholate-hydroxypyridinonate ligands.锕系元素的特异性螯合剂。21. 八齿混合儿茶酚盐-羟基吡啶酮配体的合成及初步生物学测试。
J Med Chem. 1993 Feb 19;36(4):504-9. doi: 10.1021/jm00056a011.
6
Chelation Behaviors of 3,4,3-LI(1,2-HOPO) with Lanthanides and Actinides Implicated by Molecular Dynamics Simulations.通过分子动力学模拟研究 3,4,3-LI(1,2-HOPO)与镧系和锕系元素的螯合行为。
Inorg Chem. 2023 Mar 13;62(10):4304-4313. doi: 10.1021/acs.inorgchem.2c04460. Epub 2023 Feb 27.
7
Hydroxypyridinone Derivatives: A Low-pH Alternative to Polyaminocarboxylates for TALSPEAK-like Separation of Trivalent Actinides from Lanthanides.羟基吡啶酮衍生物:一种用于从镧系元素中类似TALSPEAK法分离三价锕系元素的低pH值替代多氨基羧酸盐的试剂。
ACS Omega. 2020 May 28;5(22):12996-13005. doi: 10.1021/acsomega.0c00873. eCollection 2020 Jun 9.
8
Selective Lanthanide Sensing with Gold Nanoparticles and Hydroxypyridinone Chelators.金纳米粒子和羟吡啶酮螯合剂对镧系元素的选择性传感。
Inorg Chem. 2020 Feb 3;59(3):2030-2036. doi: 10.1021/acs.inorgchem.9b03393. Epub 2020 Jan 23.
9
Siderocalin-mediated recognition, sensitization, and cellular uptake of actinides.铁调素介导的锕系元素识别、致敏及细胞摄取
Proc Natl Acad Sci U S A. 2015 Aug 18;112(33):10342-7. doi: 10.1073/pnas.1508902112. Epub 2015 Aug 3.
10
Chelating agents for uranium(VI): 2. Efficacy and toxicity of tetradentate catecholate and hydroxypyridinonate ligands in mice.用于铀(VI)的螯合剂:2. 四齿儿茶酚和羟基吡啶酮配体在小鼠体内的疗效和毒性
Health Phys. 2000 May;78(5):511-21. doi: 10.1097/00004032-200005000-00008.

引用本文的文献

1
The K/Y cationic exchange in a C-symmetric metallamacrocyclic scaffold: DFT examination with QTAIM, ELF, MEP approaches and XRD study of the final alaninehydroximate complex.C对称金属大环支架中的K/Y阳离子交换:采用QTAIM、ELF、MEP方法的密度泛函理论研究以及最终丙氨酸肟配合物的X射线衍射研究
J Mol Model. 2025 Jun 4;31(7):180. doi: 10.1007/s00894-025-06409-5.
2
Actinium chelation and crystallization in a macromolecular scaffold.在大分子支架中锕的螯合和结晶。
Nat Commun. 2024 Jul 15;15(1):5741. doi: 10.1038/s41467-024-50017-5.

本文引用的文献

1
Developing scandium and yttrium coordination chemistry to advance theranostic radiopharmaceuticals.发展钪和钇配位化学以推进诊疗用放射性药物。
Commun Chem. 2020 May 15;3(1):61. doi: 10.1038/s42004-020-0307-0.
2
Y PET imaging.正电子发射断层扫描(PET)成像。
Methods Enzymol. 2021;651:313-342. doi: 10.1016/bs.mie.2020.12.013. Epub 2021 Jan 6.
3
Development of Antibody Immuno-PET/SPECT Radiopharmaceuticals for Imaging of Oncological Disorders-An Update.用于肿瘤疾病成像的抗体免疫正电子发射断层显像/单光子发射计算机断层显像放射性药物的进展——最新情况
Cancers (Basel). 2020 Jul 11;12(7):1868. doi: 10.3390/cancers12071868.
4
Y-Labeled Monoclonal Antibody Targeting Tissue Factor for Pancreatic Cancer Theranostics.用于胰腺癌治疗诊断的 Y 型标记组织因子单克隆抗体
Mol Pharm. 2020 May 4;17(5):1697-1705. doi: 10.1021/acs.molpharmaceut.0c00127. Epub 2020 Mar 31.
5
Y-Based Theranostics Targeting Angiogenesis in a Murine Breast Cancer Model.基于 Y 的治疗策略靶向小鼠乳腺癌模型中的血管生成。
Mol Pharm. 2018 Jul 2;15(7):2606-2613. doi: 10.1021/acs.molpharmaceut.8b00133. Epub 2018 May 30.
6
Screening, large-scale production and structure-based classification of cystine-dense peptides.胱氨酸致密肽的筛选、大规模生产和基于结构的分类。
Nat Struct Mol Biol. 2018 Mar;25(3):270-278. doi: 10.1038/s41594-018-0033-9. Epub 2018 Feb 26.
7
Design of Radioiodinated Pharmaceuticals: Structural Features Affecting Metabolic Stability towards in Vivo Deiodination.放射性碘化药物的设计:影响体内脱碘代谢稳定性的结构特征
European J Org Chem. 2017 Jun 30;2017(24):3387-3414. doi: 10.1002/ejoc.201601638. Epub 2017 Apr 26.
8
The Beginning and Development of the Theranostic Approach in Nuclear Medicine, as Exemplified by the Radionuclide Pair Y and Y.核医学中诊疗一体化方法的起源与发展,以放射性核素对Y和Y为例
Pharmaceuticals (Basel). 2017 Jun 20;10(2):56. doi: 10.3390/ph10020056.
9
Engineered Recognition of Tetravalent Zirconium and Thorium by Chelator-Protein Systems: Toward Flexible Radiotherapy and Imaging Platforms.螯合剂-蛋白质系统对四价锆和钍的工程识别:迈向灵活的放射治疗和成像平台
Inorg Chem. 2016 Nov 21;55(22):11930-11936. doi: 10.1021/acs.inorgchem.6b02041. Epub 2016 Nov 1.
10
p-SCN-Bn-HOPO: A Superior Bifunctional Chelator for (89)Zr ImmunoPET.p-SCN-Bn-HOPO:一种用于(89)Zr免疫正电子发射断层显像的优质双功能螯合剂。
Bioconjug Chem. 2015 Dec 16;26(12):2579-91. doi: 10.1021/acs.bioconjchem.5b00572. Epub 2015 Nov 25.